vimarsana.com
Home
Live Updates
MindMed Completes Enrollment of Phase 2a Trial of MM-120 in
MindMed Completes Enrollment of Phase 2a Trial of MM-120 in
MindMed Completes Enrollment of Phase 2a Trial of MM-120 in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)
– 53 participants enrolled across two sites –
...
Related Keywords
Canada ,
Canadian ,
Robert Barrow ,
Company Phase ,
Company Quarterly Report On Form ,
Nasdaq ,
Company Annual Report On Form ,
Company Or Mindmed ,
Exchange Commission ,
Medicine Mindmed Inc ,
Mind Medicine ,
Chief Executive Officer ,
Symptom Rating Scale ,
Annual Report ,
Quarterly Report ,
Note Regarding Forward Looking Statements ,
Financial Condition ,
Markets ,